Aziriv Film-Coated Tablets

The active substance is rivaroxaban. AZIRIV belong to a group of medicines called antithrombotic medicines. It works by blocking a blood clotting factor 25 (Factor Xa) and thus reduces the tendency of the blood to clot.

AZIRIV 15 and 20 mg tablets are used to:

• prevent blood clots in the brain (stroke) and other blood vessels in your body if you have a form of irregular heart rhythm called non-valvular atrial fibrillation
• treat blood clots in the veins of your legs (deep vein thrombosis) and to prevent blood clots from re-occurring in the veins of your legs and/or lungs (pulmonary embolism)
• treat blood clots in the blood vessels of your lungs (pulmonary embolism) and to prevent blood clots from re-occurring in the blood vessels of your lungs and/or legs (deep vein thrombosis).

Do not take AZIRIV and tell your doctor if any of the following apply to you:

• if you are allergic (hypersensitive) lo rivaroxaban or any of the other ingredients of AZIRIV
• if you have an inherited bleeding disorder
• if you have a liver disease which leads to an increased risk of bleeding
• if you have been diagnosed with persistent triple positive antiphospholipid syndrome (APS)
• if you are pregnant or breastfeeding.

Warnings and precautions

Take special care with AZIRIV:

• if you have moderate or severe kidney disease
• if you have moderate liver disease
• if you know that you have a disease called antiphospholipid syndrome (a disorder of the immune system that causes an increased risk of blood clots).
• if you have an increased risk of bleeding such as:

• bleeding disorders
• very high blood pressure, not controlled by medical treatment
• active ulcer or a recent ulcer of your stomach or bowel
• a problem with the blood vessels in the back of your eyes (retinopathy)
• recent bleeding in your brain (intracranial or intracerebral bleeding)
• problems with your blood vessels in your brain or spinal column
• a recent operation on your brain, spinal column or eye
• a lung disease where your bronchi are widened and filled with pus (bronchiectasis), or
• previous bleeding from your lung.

• if you have an artificial heart valve. Tell your doctor before you take AZIRIV if any of these apply to you. Your doctor may decide if you should be treated with AZIRIV or if you should be kept under closer observation.

If you need to have an operation:

• it is very important to take AZIRIV before and after the operation exactly at the times you have been told by your doctor. Inform your doctor that you are taking AZIRIV.

If your operation involves a catheter or injection into your spinal column (e.g. for epidural or spinal anaesthesia or pain reduction):

• it is very important to take AZIRIV before and after the injection or removal of the catheter exactly at the times you have been told by your doctor
• tell your doctor immediately if you get numbness or weakness of your legs or problems with your bowel or bladder after the end of anaesthesia, because urgent care is necessary.

Children and adolescents

AZIRIV is not recommended for people under 18 years of age. There is not enough information on its use in children and adolescents.

Other medicines and AZIRIV

Always tell your health care provider if you are taking any other medicine. (This includes all complementary or traditional medicines.)

If you are taking:

• some medicines for fungal infections (e.g. ketoconazole, itraconazole, voriconazole, posaconazole), unless they are only applied to the skin
• some antiretroviral medicines for HIV/AIDS (e.g. ritonavir)
• other medicines to reduce blood clotting (e.g. enoxaparin or clopidogrel or Vitamin K antagonists such as warfarin and acenocoumarol)
• anti-inflammatory and pain relieving medicines (e.g. naproxen or acetylsalicylic acid).

Tell your doctor before taking AZIRIV because its effect may be increased. Your doctor will decide if you should be treated with AZIRIV and if you should be kept under closer observation.

If your doctor thinks that you are at an increased risk to develop an ulcer of your stomach or bowel, he/she may also use a preventative ulcer treatment.

If you are taking:

• some medicines for treatment of epilepsy (phenytoin, carbamazepine, phenobarbital)
• St John's Wort, a herbal product used for depression
• rifampicin, an antibiotic.

Tell your doctor before taking AZIRIV, because its effect may be reduced. Your doctor will decide if you should be treated with AZIRIV and if you should be kept under closer observation.

AZIRIV with food, drink and alcohol

AZIRIV must be taken with food.

Pregnancy, breastfeeding and fertility

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, please consult your doctor, pharmacist or other health care provider for advice before taking AZIRIV. If you are pregnant or breastfeeding do not take AZIRIV. If there is a chance that you could become pregnant, use a reliable contraceptive while you are taking AZIRIV. If you become pregnant while you are taking AZIRIV, immediately tell your doctor, who will decide how you should be treated. There is no information on fertility with AZIRIV.

Driving and using machines

AZIRIV may cause side effects such as dizziness or fainting (see "Possible side effects"). You should not drive or use machines if you are affected by these symptoms.

Important information about some of the ingredients of AZIRIV: Lactose intolerance: AZIRIV contains lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking AZIRIV.

Do not share medicines prescribed for you with any other person. Always take AZIRIV exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

How much to take:

• To prevent blood clots in the veins after a hip or knee replacement operation The recommended dose is one tablet AZIRIV 10 once a day.
• To prevent blood clots in the brain (stroke) and other blood vessels in your body: The usual dose is one AZIRIV 20 tablet once a day. If your kidneys are not working properly, the dose may be reduced to one AZIRIV 15 tablet once a day.
• To treat blood clots in the veins of your legs and for preventing blood clots from re-occurring: The usual dose is one AZIRIV 15 tablet twice a day for the first 3 weeks. For treatment after 3 weeks, the usual dose is one AZIRIV 20 tablet once a day.
• To treat blood clots in the blood vessels of your lungs and for preventing blood clots from re-occurring The usual dose is one AZIRIV 15 tablet twice a day for the first 3 weeks. For treatment after 3 weeks, the usual dose is one AZIRIV 20 tablet once a day.

Swallow the tablet preferably with water. AZIRIV must be taken with food.

When to take AZIRIV: Take the tablet(s) every day until your doctor tells you to stop. Try to take the tablet(s) at the same time every day to help you to remember it. Your doctor will decide how long you must continue treatment for.

If you take more AZIRIV than you should: Contact your doctor immediately if you have taken too many AZIRIV tablets. Taking too much AZIRIV increases the risk of bleeding. In the event of overdosage, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison centre.

If you forget to take AZIRIV:

• If you are taking one AZIRIV tablet once a day and have missed a dose, take it as soon as you remember. Do not take more than one tablet in a single day to make up for a forgotten dose. Take the next tablet on the following day and then carry on taking one tablet once a day.
• If you are taking one AZIRIV 10 or one AZIRIV 15 tablet twice a day and have missed a dose, take it as soon as you remember. Do not take more than two AZIRIV 10 or AZIRIV 15 tablets in a single day. If you forget to take a dose you can take two AZIRIV 10 or AZIRIV 15 tablets at the same time to get a total of two tablets (20 mg or 30 mg respectively) on one day. On the following day you should carry on taking one AZIRIV 10 or AZIRIV 15 tablet twice a day.

If you stop taking AZIRIV: Don’t stop taking AZIRIV without talking to your doctor first, because AZIRIV treats and prevents serious conditions. If you have any further questions on the use of AZIRIV, ask your doctor or pharmacist.

AZIRIV can have side effects. Not all side effects reported for AZIRIV are included in this leaflet. Should your general health worsen or if you experience any untoward effects while taking AZIRIV, please consult your health care provider for advice. AZIRIV may cause bleedings which may potentially be life threatening. Excessive bleeding may lead to sudden drop in blood pressure (shock). In some cases, these bleedings may not be obvious.

If any of the following happens, stop taking AZIRIV and tell your doctor immediately or go to the casualty department at your nearest hospital. Tell your doctor immediately, if you experience any of the following side effects:

• long or excessive bleeding
• exceptional weakness, tiredness, paleness, dizziness, headache, unexplained swelling, breathlessness, chest pain (angina pectoris). These may be signs of bleeding.

Tell your doctor immediately if you experience skin reactions such as:

• spreading intense skin rash, blisters or mucosal lesions, e.g. in the mouth or eyes (Stevens-Johnson syndrome/toxic epidermal necrolysis).
• a drug reaction that causes rash, fever, inflammation of internal organs, hematologic abnormalities, and systemic illness (DRESS syndrome).

Tell your doctor immediately, if you experience any of the following side effects:

• swelling of the face, lips, mouth, tongue or throat; difficulty swallowing; hives and breathing difficulties; sudden drop in blood pressure.

Your doctor may decide to keep you under closer observation or change how you should be treated. It has been reported for AZIRIV that the following side effects can occur:

Frequent side effects:

• bleeding in the stomach or bowel, urogenital bleeding (including blood in the urine and heavy menstrual bleeding). nose bleed, bleeding in the gum
• bleeding into the eye (including bleeding from the whites of the eyes)
• bleeding into tissue or a cavity of the body (haematoma, bruising)
• bleeding following an operation
• swelling in the limbs
• pain in the limbs
• fever
• reduction in red blood cells which can make the skin pale and cause weakness or breathlessness
• stomach ache, indigestion, feeling or being sick, constipation, diarrhoea
• low blood pressure
• decreased general strength and energy (weakness, tiredness), headache, dizziness
• rash, itchy skin
• blood tests may show an increase in some liver enzymes
• impaired function of the kidneys
• bleeding from the skin or under the skin
• coughing up blood.

Less frequent side effects:

• bleeding into the brain or inside the skull
• bleeding into a joint causing pain and swelling
• thrombocytopenia (low number of platelets, which are cells that help blood to clot)
• oozing of blood or fluid from surgical wound
• feeling unwell
• dry mouth
• allergic reactions, including allergic skin reactions
• hives
• impaired function of the liver
• blood tests may show an increase in bilirubin, some pancreatic or liver enzymes or in the number of platelets
• raised heartbeat
• fainting
• bleeding into a muscle
• collection of blood (haematoma) following complication in a cardiac procedure where a catheter is inserted in your leg artery (pseudoaneurysm)
• localised swelling
• cholestasis (decreased bile flow), hepatitis incl. hepatocellular injury (inflamed liver incl. liver injury)
• yellowing of the skin and eye (jaundice).

Frequency unknown:

• kidney failure after a severe bleeding
• increased pressure within muscles of the legs or arms after a bleeding, which leads to pain, swelling, altered sensation, numbness or paralysis (compartment syndrome after a bleeding)

If any of these side effects continue or become bothersome, consult your health care provider. If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.

Reporting of side effects

If you get side effects, talk to your doctor, pharmacist or nurse. You can also report side effects to SAHPRA via the “6.04 Adverse Drug Reactions Reporting Form”, found online under SAHPRA’s publications: https://www.sahpra.org.za/Publications/Index/8. By reporting side effects, you can help provide more information on the safety of AZIRIV.

Store all medicines out of reach of children. Store at or below 25°C. Store in the original package until use.